2011
DOI: 10.1007/s10147-010-0169-z
|View full text |Cite
|
Sign up to set email alerts
|

Oral premalignant lesions: from the pathological viewpoint

Abstract: Under the widely used World Health Organization (WHO) classification for the pathological diagnosis of oral premalignant lesions, dysplasia, which is graded as mild, moderate or severe, and carcinoma in situ (CIS), which is a non-invasive carcinoma, are classified as precursor lesions of oral squamous cell carcinoma. Since the first edition (Wahi et al. International histological classification of tumours no. 4, WHO, Geneva, 1971), the criterion for CIS--that all epithelial layers are replaced by atypical cell… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
60
0
4

Year Published

2012
2012
2020
2020

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(65 citation statements)
references
References 82 publications
0
60
0
4
Order By: Relevance
“…However, screening for head and neck cancer in premalignant stages and identifying oral premalignant lesions (dysplasia) at high risk of transformation is currently unpredictable. [5][6][7][8]41,42 Furthermore, the histological diagnosis of dysplasia can be subjective and is thus prone to considerable variations in interpretations among pathologists. Thus, molecular biomarkers capable of identifying the subset of lesions likely to progress to cancer are required to eliminate this clinical diagnostic dilemma.…”
Section: Discussionmentioning
confidence: 99%
“…However, screening for head and neck cancer in premalignant stages and identifying oral premalignant lesions (dysplasia) at high risk of transformation is currently unpredictable. [5][6][7][8]41,42 Furthermore, the histological diagnosis of dysplasia can be subjective and is thus prone to considerable variations in interpretations among pathologists. Thus, molecular biomarkers capable of identifying the subset of lesions likely to progress to cancer are required to eliminate this clinical diagnostic dilemma.…”
Section: Discussionmentioning
confidence: 99%
“…The accelerated pace of cell division noted at the earlier stages of transformation as a part of adaptive response (to replace the damaged cell pool) is, in a way, facilitative of the accumulation of further genetic damage, thereby driving the cells further along the path of transformation. [13,14] Clinical classification: [15]  o Phase IV: Erythroleukoplakia -poor prognosis. [10] The current "gold standard" for predicting the malignant potential of premalignant lesions is the presence and degree of dysplasia.…”
Section: Etiologymentioning
confidence: 99%
“…The clinical appearance of non-homogeneous or speckled OL may correlate with the likelihood that the lesion will show epithelial changes or malignant transformation. In a study by Silverman and co-workers, the overall malignant Table 1 Modified review of Izumo [14] presenting six classifications of oral and laryngeal precursor lesions [2,7,[15][16][17] WHO-DC World Health Organization dysplasia system; CIS carcinoma in situ; SIN squamous intraepithelial neoplasia; LC Ljubljana classification; SIL squamous intraepithelial lesions; OIN oral intraepithelial neoplasia; OED oral epithelial dysplasia; JSOP Japanese Society for Oral Pathology [22]. Compared to OL, oral erythroplakia has significantly worse biological behavior, with up to 50 % of malignant transformation [23].…”
Section: Oral Cavitymentioning
confidence: 99%
“…Numerous articles have reported attempts to evaluate the reliability and inter-observer agreement of these grading systems for oral and laryngeal SILs [6][7][8][9][10][11][12][13]. Some of them have also compared WHO grading systems with new proposals, such as a binary grading system and other classifications for oral lesions or, more widely, for the whole head and neck region (Table 1) [2,7,9,[15][16][17].…”
Section: Introductionmentioning
confidence: 99%